Prostate Cancer Antibodies
Prostate cancer is the 3rd highest diagnosed cancer in the United States, with about 13.3% of new cancer cases classified as prostatic, contributing approx. 4.7% of cancer deaths yearly. As of 2012, there were approximately 2,795,000 men living with prostate cancer in the United States. Those diagnosed with prostate cancer have a 5 year survival rate of 98.9%. Over the last 10 years, the new cancer case rate has dropped an average of 4.3% each year while the death rate has not changed significantly. Biocare Medical is proud to offer key prostate antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Prostate Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/prost.html